Search

Research

Antibodies that target immune checkpoints such as cytotoxic T lymphocyte antigen 4 (CTLA‐4) and the programmed cell death protein 1/ligand 1 (PD-1/PD-L1) are now a treatment option for multiple cancer types. However, as a monotherapy, objective responses only occur in a minority of patients. Chemotherapy is widely used in combination with immune checkpoint blockade (ICB). Although a variety of isolated immunostimulatory effects have been reported for several classes of chemotherapeutics, it is unclear which chemotherapeutics provide the most benefit when combined with ICB.

Research

One of the major challenges in health studies with a spatial dimension is to produce valid and meaningful geographical representations of risk.

News & Events

We spoke to Oscar and asked him to share his story about the challenges he faces when trying to support his brother, joining the Centre as a student and what T1D research means to him, his brother and his family.

News & Events

Diabetes Research Western Australia (DRWA) are inviting children aged 6-16 living with type 1 and type 2 diabetes to join West Coast Eagles forward Jamie Cripps for a fun-filled footy clinic. 

News & Events

With Term 2 commencing this week, many parents are unsure as to whether to send their child with type 1 diabetes back to school. To assist parents with their own decision-making process, it is important to consider the individual risks and benefits for each family.

An adapted novel flow cytometry methodology to delineate types of cell death in airway epithelial cells Cystic fibrosis (CF) lung disease is

Research

In this review article we systematically summarize the evidence for an impact on lung development of 1) maternal ingestion of arsenic contaminated drinking...

News & Events

Are you tired of being on waitlists to access supports for your family? CliniKids has immediate availability for a number of therapies and programs in clinic (Subiaco and Joondalup) or via telehealth.

News & Events

We have been advised by the Department of Infectious Diseases at Perth Children's Hospital and the Wesfarmers Centre of Vaccines and Infectious Diseases at The Kids Research Institute Australia that COVID-19 vaccinations are now available for young children aged 6 months to 4 years with type 1 diabetes.

News & Events

Kids living with Type 1 Diabetes were literally blown away when the Westpac Lifesaver Rescue Helicopter dropped in at the Diabetes WA and PMH kids' camp.